izocorp.com Open in urlscan Pro
44.242.131.195  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This web site uses cookies to enhance your experience. Please accept to close
this banner. Learn more
I Accept
 * CSE: IZO
 * OTCQB: IZOZF
 * FSE: 1R3

 * 
 * 
 * 

 * Home
 * Investors
    * Stock Info
    * Financials
    * Presentation
    * Fact Sheet
    * Management
    * Advisors

 * Media
    * IzoView Images
    * Videos

 * News
 * Contact

Menu


INTRODUCING IZOVIEW


LATEST NEWS

 * 6/14/2024 Izotropic Announces Closing of First Tranche of Non-Brokered
   Private Placement Read More
 * 6/6/2024 Izotropic Corporation Announces Non-Brokered Private Placement- June
   2026 Read More
 * 1/30/2024 Izotropic Receives Response From U.S. FDA Read More


SIGN UP FOR EMAIL UPDATES

Subscribe Now

1-833-IZOCORP | INFO@IZOCORP.COM

Corporate Presentation

Video Presentation



STOCK INFO

SYMBOL

CSE: IZO
OTCQB: IZOZF
FSE: 1R3


SHARE STRUCTURE

SHARES OUTSTANDING

54,996,346


FINANCIALS

FOR THE NINE MONTHS ENDED JANUARY 31, 2024

FS MDA


MANAGEMENT TEAM


 * ROBERT THAST
   
   Interim CEO
   
   Founding CEO of Izotropic, Mr. Thast has served as board chairman, chief
   executive officer, senior executive, and director of several publicly listed
   companies. He has expertise in several fields, ... Read More


 * DR. JOHN BOONE
   
   Ph.D., Principal Founder of Breast CT, Director
   
   Dr. Boone is a medical physicist with 32 years of experience in academia,
   with broad interests in medical imaging, computed tomography, and breast
   computed tomography. He has been the principal inv... Read More


 * DR. YOUNES ACHKIRE
   
   Ph.D., Chief Operating Officer
   
   Dr. Younes Achkire has over 20 years of engineering experience from startups
   to working with large teams in established organizations and brings a unique
   combination of business development, produc... Read More


 * RALPH PROCEVIAT
   
   CPA, CFO, Director
   
   Mr. Proceviat has more than 35 years in business, finance, markets and
   operations spanning several industries operating in Canada, Europe and the
   United States. He is a member of the Chartered Prof... Read More


 * ALI SODAGAR
   
   Legal Advisor, Director
   
   Founder of multidisciplinary law firm Sodagar & Company Law Corp., Mr.
   Sodagar specializes in international business and commercial law, project
   finance, mergers and acquisitions, intellectual ... Read More


 * ALEXANDER TOKMAN
   
   Director
   
   Mr. Tokman is a growth-driven executive leader with over 22 years of global,
   cross-functional profit and loss leadership, specializing in creating and
   commercializing new technology businesses in t... Read More


 * JACLYN THAST
   
   Corporate Secretary & Operations Manager
   
   Ms. Thast is responsible for all listing compliance matters and public
   company filings, news release research and drafting, board and management
   communications, accounting, all company administrati... Read More

Suite 424, 800-15355 24th Avenue, Surrey, BC, V4A 2H9
1-833-IZOCORP info@izocorp.com

 * Home
 * Investors
 * Media
 * News
 * Contact

© 2024 Izotropic Corporation | Disclaimer | Site by Adnet


 * Investors
   * Stock Info
   * Financials
   * Presentation
   * Fact Sheet
   * Management
   * Advisors
 * Media
   * IzoView Images
   * Videos
 * News
   * Izotropic Announces Closing of First Tranche of Non-Brokered Private
     Placement
   * Izotropic Corporation Announces Non-Brokered Private Placement- June 2026
   * Izotropic Receives Response From U.S. FDA
   * Izotropic Provides Regulatory and Operational Updates
   * Izotropic Announces AGM Results- 2023
   * Izotropic Completes Pre-Submission Meeting With U.S. FDA
   * Izotropic Confirms FDA Pre-Submission Meeting Date
   * Izotropic Closes Non-Brokered Private Placement- September 2023
   * Izotropic Corporation Announces Non-Brokered Private Placement- September
     2023
   * Izotropic Files Class II Pre-Submission with FDA & Releases Details On
     Predicate Devices
   * Izotropic Engages Market Awareness Consultant
   * Izotropic Modifies Market Approval Pathway & Strategy
   * Izotropic CEO Resigns
   * Izotropic Completes QSUB Meeting with FDA Regarding Clinical Study
     Acceleration
   * Izotropic Provides Business Update
   * Izotropic to Extend Period for Unsecured Loans
   * Izotropic’s Technical & Scientific Team Members Advocate for
     Commercialization of Breast CT Technology
   * Izotropic’s IzoView Breast CT Device To Be Featured On Advancements TV Show
     In USA
   * Izotropic Creates Compensation Committee and Adopts Charter
   * Izotropic Releases First Video of IzoView
   * Izotropic Reports Board Meeting Results
   * Izotropic Delays Announcements to 2023, Holds Board Meeting
   * Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial
     Statements
   * Izotropic Corporation Files Amended and Restated Financial Statements For
     July 31, 2022
   * Izotropic Completes IzoView Development and Assembly, Prepares for Final
     Testing
   * Alexander Tokman Joins Izotropic Board of Directors
   * Izotropic Corporation Announces Closing Of Non-Brokered Private Placement-
     Nov 2022
   * Izotropic Grants Stock Options
   * Izotropic's IzoView is Weeks Away From Final Engineering & Showcasing to
     Investment and Scientific Communities
   * Izotropic Finalizes Engineering and Development Transition to The United
     States; Establishes Operations in Primary Target Market
   * Izotropic Engages Clinical Research Organization in Preparation for
     Clinical Study
   * Izotropic Reacts to Supply Chain Disruptions and Updates IzoView
     Engineering Timelines
   * Izotropic Unveils IzoView Commercial Prototype, Files New Patents
   * Izotropic Targets the Modern Investor and Engages Grit Capital
   * Izotropic Moves to Educate New Demographics On Breast CT, Engages New
     Consultants for Investor Relations & Awareness
   * Izotropic Announces Investor Conference Schedule
   * Izotropic Corporation Announces Closing of Non-Brokered Private Placement
   * Izotropic Corporation Announces Non-Brokered Private Placement
   * Breast CT Authority and Head of Clinical Trials Joins Izotropic
   * Izotropic Establishing Engineering and Development Facility in the USA
   * Izotropic Implements Quality Management System For Izoview Breast CT Device
     Manufacturing
   * Izotropic’s Breast CT Radiation Imaging Subsystem Powered On and Takes
     Initial Images
   * Izotropic Appoints Breast CT Expert As Head Of Imaging Technology
   * Izotropic Announces 2021 AGM Results
   * Izotropic Reaches Q3 Milestones and Provides Engineering Update
   * Izotropic Signs Agreement With Johns Hopkins University School of Medicine
     to Develop Deep Machine Learning Algorithms for IzoView Breast CT
   * Izotropic Nominated For Best New Radiology Device Award
   * Izotropic Receives Notice of Allowance For New 3D X-Ray Beam Filter Patent
     From USPTO
   * Izotropic Engages Consultants for Investor Relations and Dedicated Social
     Media and Communications Services
   * Izotropic Appoints Medical Device R&D Expert as Executive VP of Product
     Engineering
   * Izotropic Updates Timelines for Clinical Study and Fabrication of Initial
     Izoview Units
   * Izotropic Provides Corporate Update
   * Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
   * Izotropic Accelerates Payor Engagement Activities with Excite International
   * Izotropic Launches Marketing Campaign
   * Izotropic Appoints Dr. John McGraw as Chief Executive Officer
   * Initial Insurance Billing Codes Issued for Dedicated Breast CT in the USA
   * Izotropic Launches New Website and Corporate Presentation
   * Izotropic Unveils “izoview” Branding For Breast CT Platform In Development
     And Files Trademark Applications
   * Izotropic Announces Upgrade to OTCQB Venture Market
   * Izotropic Grants Restricted and Performance Share Units
   * 3D CT Imaging Expert Joins Izotropic Advisory
   * Izotropic Positioned to Execute in 2021
   * Izotropic Technology Founder Appointed Editor-In-Chief Of Medical Physics
     Journal
   * Izotropic Reports High Degree of Confidence After Pre-Submission Meeting
     With FDA
   * Izotropic Corporation Announces Closing of Non-Brokered Private Placement
   * Izotropic Cancels Options and Updates Amount of Broker Warrant Issued
   * Izotropic Engages Investor Relations and Market Awareness Consultants
   * Izotropic Corporation Announces Closing of Second Tranche of Non-Brokered
     Private Placement
   * Izotropic Unaware of Any Material Change
   * Izotropic Corporation Announces Non-Brokered Private Placement
   * Izotropic Announces 2020 AGM Results
   * Izotropic Announces Meeting Date With FDA
   * Mr. Alexander Tokman Joins Izotropic as Strategic Advisor
   * Izotropic Engages Marketsmart Communications
   * Izotropic Appoints Jaclyn Thast as Corporate Secretary
   * Izotropic Files Pre-Submission Application With U.S. FDA
   * Izotropic Unaware of Any Material Change
   * Izotropic Corporation Announces Adoption of Long Term Incentive Plan
   * Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design
   * Izotropic Corporation Appoints Executive Vice President of Commercial
     Operations
   * Izotropic Engages Mr. James Berard for Investor Relation Services
   * Izotropic Corporation Announces Warrant Amendment
   * Izotropic Corporation Announces Issuance of Warrants Pursuant to January
     Warrant Incentive Program, Delayed Due to Covid-19
   * Izotropic Begins FDA Approval Process
   * FDA Consultant Joins Izotropic Advisory Board
   * Izotropic Engages Starfish Medical for Design and Development of Commercial
     Breast CT Model
   * Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided
     Biopsy
   * Izotropic Announces Addition of George Burkett, M.Eng to Advisory Board
   * Izotropic Announces Issuance of Patent to Measure Breast Density With
     Breast CT Technology
   * Izotropic Provides Update on Globally Licensed Breast CT Technology
   * Izotropic Successfully Extends Exclusive Global License Agreement for
     Innovative Breast CT Technology Until 2027
   * Izotropic Receives Notice of Allowance for Measuring Breast Density From US
     Patent Office
   * Izotropic Corporation Announces Apppointment of Dr. John Mcgraw to Advisory
     Board
   * Izotropic Corporation Raises $1.23M From Warrant Exercise Program
   * Izotropic Corporation Receives Notice of Allowance From US Patent Office
   * Izotropic Corporation Announces Warrant Exercise Incentive Program
   * Izotropic Corporation Announces Cancellation and Issuance of Stock Options
   * What Could Google’s AI Capability Do with Real 3D Breast CT Images?
 * Contact